Posts about

Oncology

SOCIAL MEDIA INSIGHTS - 2022 ASCO ANNUAL MEETING

Digital, hemato-oncology, Social Media Listening, Oncology

The American Society of Clinical Oncology (ASCO) annual meeting is a flagship event in the global...

Social Media insights - 2021 ASCO annual meeting

Digital, hemato-oncology, Social Media Listening, Oncology

The American Society of Clinical Oncology (ASCO) annual meeting is a flagship event in the global...

MDS: Treatment paradigms are changing

hemato-oncology, Tracking Studies, Syndicated Studies, Oncology

MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment...

mRCC: promising new combinations lead to disruption in L1 and L2

Syndicated Studies, Oncology

Targeted therapies, particularly tyrosine kinase inhibitors (TKI) dominate the treatment of...

Social Media Insights: ASCO 2020 Part 2

hemato-oncology, Social Media Listening, Oncology

The American Society of Oncologists (ASCO) annual meeting is a major fixture in the global oncology 

Social Media Insights: ASCO 2020 Part 1

hemato-oncology, Social Media Listening, Oncology

The American Society of Oncologists (ASCO) annual meeting is a major fixture in the global oncology 

Social Media Listening: Insights from Healthcare conferences

Market Research Industry, hemato-oncology, Social Media Listening, Oncology

Healthcare conferences provide unique opportunities to gain first-hand insights from otherwise...

DLBCL Market Overview

hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology

Following the release of our latest ebook, this is the first blog post in this series focusing on...

New AplusA eBook Covers the DLBCL Market

AplusA News, hemato-oncology, Tracking Studies, DLBCL market, Syndicated Studies, Oncology

Introducing the latest eBook in AplusA's Hemato-Oncology series

 

DLBCL Case Study: Enhancing Patient Journey Research with Social Media Listening

hemato-oncology, DLBCL market, Social Media Listening, Syndicated Studies, Oncology

Using the example of a recent AplusA study in Diffuse Large B-Cell Lymphoma (DLBCL), we consider...